T Peters

Dr. T Peters

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2007 in Nature Genetics
Verified
Journal Article
Closed access
HAHeleen H Arts
Heleen H Arts
DDDan Doherty
Dan Doherty
SBSylvia E C van Beersum
Sylvia E C van Beersum
MPMelissa A Parisi
Melissa A Parisi
SLStef J F Letteboer
Stef J F Letteboer
RRRonald Roepman
Ronald Roepman

2 October 2006 in Journal of Cell Biology
Verified
Journal Article
Open access
NSNorman Sachs
Norman Sachs
MKMaaike Kreft
Maaike Kreft
MWMarius A. van Den Bergh Weerman
Marius A. van Den Bergh Weerman
ABAndy J. Beynon
Andy J. Beynon
TPT Peters
T Peters
ASArnoud Sonnenberg
Arnoud Sonnenberg
The tetraspanin CD151 is a cell-surface molecule known for its strong lateral interaction with the laminin-binding integrin α3β1. Patients with a nonsense mutation in CD151 display end-stage kidney failure associated with regional skin blistering and sensorineural deafness, and mice lacking the integrin α3 subunit die neonatally because of severe abnormalities in the lung and kidney epithelia. We report the generation of Cd151-null mice that recapitulate the renal pathology of human patients, i.e., with age they develop massive proteinuria caused by focal glomerulosclerosis, disorganization of the glomerular basement membrane, and tubular cystic dilation. However, neither skin integrity nor hearing ability are impaired in the Cd151-null mice. Furthermore, we generated podocyte-specific conditional knockout mice for the integrin α3 subunit that show renal defects similar to those in the Cd151 knockout mice. Our results support the hypothesis that CD151 plays a key role in strengthening α3β1-mediated adhesion in podocytes.

24 January 2006 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
EWErwin van Wijk
Erwin van Wijk
BZBert van der Zwaag
Bert van der Zwaag
TPT Peters
T Peters
UZUlrike Zimmermann
Ulrike Zimmermann
HBHeleen Te Brinke
Heleen Te Brinke
HKHannie Kremer
Hannie Kremer
Mutations in the DFNB31 gene encoding the PDZ scaffold protein whirlin are causative for hearing loss in man and mouse. Whirlin is known to be essential for the elongation process of the stereocilia of sensory hair cells in the inner ear, though its complete spatial and temporal expression patterns remained elusive. Here, we demonstrate that, in embryonic development, the gene is not only expressed in the inner ear, but also in the developing brain and the retina. Various isoforms of whirlin are widely and differentially expressed, and we provide evidence that whirlin directly associates with USH2A isoform b and VLGR1b, two proteins that we previously reported to be part of the Usher protein interactome. These proteins co-localize with whirlin at the synaptic regions of both photoreceptor cells and outer hair cells in the cochlea. These findings indicate that whirlin is part of a macromolecular PDZ protein scaffold that functions in the organization of the pre- and/or postsynaptic side of photoreceptor and hair cell synapses. Whirlin might be involved in synaptic adhesion through interaction with USH2A and VLGR1b as well as in synaptic development as suggested by its spatial and temporal expression patterns. In addition, we demonstrate that whirlin, USH2A and Vlgr1b co-localize at the connecting cilium and the outer limiting membrane of photoreceptor cells and in spiral ganglion neurons of the inner ear. Our data show that whirlin is connected to the dynamic Usher protein interactome and indicate that whirlin has a pleiotropic function in both the retina and the inner ear.

1 August 2021 in Molecular Therapy
Verified
Journal Article
Open access
KDKalyan Dulla
Kalyan Dulla
RSRalph Slijkerman
Ralph Slijkerman
HDHester C. van Diepen
Hester C. van Diepen
SASilvia Albert
Silvia Albert
MDMargo Dona
Margo Dona
Erwin Van WijkErwin Van Wijk
Erwin Van Wijk
Mutations in USH2A are among the most common causes of syndromic and non-syndromic retinitis pigmentosa (RP). The two most recurrent mutations in USH2A, c.2299delG and c.2276G>T, both reside in exon 13. Skipping of exon 13 from the USH2A transcript presents a potential treatment modality in which the resulting transcript is predicted to encode a slightly shortened usherin protein. Morpholino-induced skipping of ush2a exon 13 in zebrafish ush2armc1 mutants resulted in the production of usherinΔexon 13 protein and a completely restored retinal function. Antisense oligonucleotides were investigated for their potential to selectively induce human USH2A exon 13 skipping. Lead candidate QR-421a induced a concentration-dependent exon 13 skipping in iPSC-derived photoreceptor precursors from an Usher syndrome patient homozygous for the c.2299delG mutation. Mouse surrogate mQR-421a reached the retinal outer nuclear layer after a single intravitreal injection, and induced a detectable level of exon skipping until at least 6 months post injection. In conclusion, QR-421a-induced exon skipping proves to be a highly promising treatment option for RP caused by mutations in USH2A exon 13.

16 June 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JSJanneke M. Stapelbroek
Janneke M. Stapelbroek
TPT Peters
T Peters
DBDenis H. A. van Beurden
Denis H. A. van Beurden
JCJo H. A. J. Curfs
Jo H. A. J. Curfs
AJAnneke Joosten
Anneke Joosten
RHRoderick H. J. Houwen
Roderick H. J. Houwen
ATP8B1 deficiency is caused by autosomal recessive mutations in ATP8B1 , which encodes the putative phospatidylserine flippase ATP8B1 (formerly called FIC1). ATP8B1 deficiency is primarily characterized by cholestasis, but extrahepatic symptoms are also found. Because patients sometimes report reduced hearing capability, we investigated the role of ATP8B1 in auditory function. Here we show that ATP8B1/Atp8b1 deficiency, both in patients and in Atp8b1 G308V/G308V mutant mice, causes hearing loss, associated with progressive degeneration of cochlear hair cells. Atp8b1 is specifically localized in the stereocilia of these hair cells. This indicates that the mechanosensory function and integrity of the cochlear hair cells is critically dependent on ATP8B1 activity, possibly through maintaining lipid asymmetry in the cellular membranes of stereocilia.

1 January 2016 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
RSRadulfus Wn Slijkerman
Radulfus Wn Slijkerman
CVChristel Vaché
Christel Vaché
MDMargo Dona
Margo Dona
GGGema García-García
Gema García-García
MCMireille Claustres
Mireille Claustres
Erwin Van WijkErwin Van Wijk
Erwin Van Wijk
Usher syndrome (USH) is the most common cause of combined deaf-blindness in man. The hearing loss can be partly compensated by providing patients with hearing aids or cochlear implants, but the loss of vision is currently untreatable. In general, mutations in the USH2A gene are the most frequent cause of USH explaining up to 50% of all patients worldwide. The first deep-intronic mutation in the USH2A gene (c.7595-2144A>G) was reported in 2012, leading to the insertion of a pseudoexon (PE40) into the mature USH2A transcript. When translated, this PE40-containing transcript is predicted to result in a truncated non-functional USH2A protein. In this study, we explored the potential of antisense oligonucleotides (AONs) to prevent aberrant splicing of USH2A pre-mRNA as a consequence of the c.7595-2144A>G mutation. Engineered 2’-O-methylphosphorothioate AONs targeting the PE40 splice acceptor site and/or exonic splice enhancer regions displayed significant splice correction potential in both patient derived fibroblasts and a minigene splice assay for USH2A c.7595-2144A>G, whereas a non-binding sense oligonucleotide had no effect on splicing. Altogether, AON-based splice correction could be a promising approach for the development of a future treatment for USH2A-associated retinitis pigmentosa caused by the deep-intronic c.7595-2144A>G mutation.